title: Bordetella holmesii bacteremia in a renal transplant recipient: emergence of a new pathogen.
abstract: Bordetella holmesii is a gram-negative rod that was initially identified in 1995. It causes bacteremia, pneumonia, and endocarditis mostly in patients with anatomical or functional asplenia. We report here, to the best of our knowledge, the first case of B. holmesii bacteremia in a renal transplant recipient following rituximab therapy for recurrence of membranoproliferative glomerulonephritis.
authors.affiliation: Service de Nephrologie-Transplantations, CHU Limoges, Hôpital Dupuytren, Limoges, France.
authors.forename: T
authors.initials: T
authors.lastname: Chambaraud
authors.forename: Z
authors.initials: Z
authors.lastname: Dickson
authors.forename: G
authors.initials: G
authors.lastname: Ensergueix
authors.forename: O
authors.initials: O
authors.lastname: Barraud
authors.forename: M
authors.initials: M
authors.lastname: Essig
authors.forename: C
authors.initials: C
authors.lastname: Lacour
authors.forename: J
authors.initials: J
authors.lastname: Allard
authors.forename: F
authors.initials: F
authors.lastname: Bocquentin
authors.forename: J C
authors.initials: JC
authors.lastname: Aldigier
authors.forename: J P
authors.initials: JP
authors.lastname: Rerolle
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D001884:Bordetella / Q000145:classification*; D001885:Bordetella Infections / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000009:adverse effects*; D008297:Male; D000069283:Rituximab
chemical_list: D000900:Anti-Bacterial Agents; D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab